Canopy Growth
Financials
Estimates*
CAD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|
Revenues | 547m | 520m | 403m | 297m | 294m | 327m | 383m |
% growth | 37 % | (5 %) | (23 %) | (26 %) | (1 %) | 11 % | 17 % |
EBITDA | 171m | (230m) | 1.7b | (88.2m) | (15.7m) | 17.3m | 26.6m |
% EBITDA margin | 31 % | (44 %) | 434 % | (30 %) | (5 %) | 5 % | 7 % |
Profit | (1.7b) | (302m) | (3.3b) | (657m) | (182m) | (105m) | (86.2m) |
% profit margin | (319 %) | (58 %) | (814 %) | (221 %) | (62 %) | (32 %) | (23 %) |
EV / revenue | 26.9x | 7.4x | 4.3x | 4.9x | 4.2x | 4.3x | 4.2x |
EV / EBITDA | 85.8x | -16.8x | 1.0x | -16.5x | -78.2x | 81.5x | 60.9x |
R&D budget | 57.6m | 32.3m | 21.7m | 4.6m | - | - | - |
R&D % of revenue | 11 % | 6 % | 5 % | 2 % | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | N/A | IPO | |
$191m | Post IPO Equity | ||
N/A | $26.0m | Post IPO Equity | |
N/A | $371m | Post IPO Debt | |
$3.8b | Post IPO Equity | ||
$174m | Private Placement VC | ||
* | $198m | Post IPO Convertible | |
* | N/A | $95.0m | Post IPO Convertible |
* | N/A | $50.0m | Private Placement VC |
* | N/A | $30.0m | Private Placement VC |
* | N/A | CAD96.4m | Post IPO Convertible |
Total Funding | €231m |
Related Content
Recent News about Canopy Growth
EditCanopy Growth Corporation is a leading player in the cannabis industry, dedicated to transforming the perception of cannabis through rigorous research, innovative product development, and advanced production techniques. The company operates in the global cannabis market, which includes both medical and recreational segments. Canopy Growth serves a diverse clientele ranging from medical patients seeking therapeutic benefits to recreational users looking for high-quality cannabis products.
The company's business model revolves around creating and marketing a wide array of cannabis products under trusted brand names. These products include dried cannabis flowers, oils, softgel capsules, and edibles. Canopy Growth also invests heavily in research and development to continually innovate and improve its product offerings. This focus on R&D helps the company stay ahead in a competitive market and meet the evolving needs of its customers.
Canopy Growth generates revenue primarily through the sale of its cannabis products. The company has a robust distribution network that includes both direct-to-consumer channels and partnerships with various retailers. Additionally, Canopy Growth has expanded its footprint internationally, tapping into emerging markets where cannabis legalization is gaining momentum.
The company is also committed to corporate social responsibility, ensuring that its operations are sustainable and socially responsible. This includes adhering to public health guidelines, especially in light of the COVID-19 pandemic, to ensure the safety of its employees and customers.
In summary, Canopy Growth Corporation is a pioneering cannabis company focused on research, product innovation, and brand trust. It serves both medical and recreational cannabis users and operates in a rapidly growing global market. The company makes money by selling a diverse range of cannabis products through a well-established distribution network.
Keywords: Cannabis, Innovation, Research, Product Development, Medical, Recreational, Brands, Global Market, Revenue, Sustainability.